[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341898-105":59,"doc-detail-341898-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mettl18-functions-as-a-phenotypic-regulator-in-src-dependent-oncogenic-responses-of-her2-negative-breast-cancer","METTL18 functions as a Phenotypic Regulator in Src-Dependent Oncogenic Responses of HER2-Negative Breast Cancer","","METTL18 is characterized as a histidine methyltransferase that targets the RPL3 protein and supports ribosome biosynthesis and translation elongation. Using biochemical, molecular, and immunological methods across breast cancer cell lines, a tumor xenograft model, and human tumor samples, the study shows METTL18 is highly amplified and elevated in HER2-negative breast cancer patients, correlating with poor prognosis. METTL18 loss markedly suppresses metastatic responses. Mechanistically, METTL18-mediated RPL3 methylation indirectly governs Src phosphorylation through the HSP90–actin pathway.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mettl18-functions-as-a-phenotypic-regulator-in-src-dependent-oncogenic-responses-of-her2-negative-breast-cancer/341898/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mettl18-functions-as-a-phenotypic-regulator-in-src-dependent-oncogenic-responses-of-her2-negative-breast-cancer/341898.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is METTL18, and what biochemical activity does it have in this study?","Question",{"text":113,"@type":114},"METTL18 is described as a histidine methyltransferase. It has histidine methyltransferase activity on the RPL3 protein, linking it to ribosome biosynthesis and translation elongation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does METTL18 relate to HER2-negative breast cancer outcomes?",{"text":118,"@type":114},"METTL18 is highly amplified and its expression is elevated in HER2-negative breast cancer patients. Higher expression is associated with poor prognosis, and METTL18 loss reduces metastatic responses in vitro and in vivo.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism connects METTL18 to Src and actin polymerization?",{"text":122,"@type":114},"METTL18 indirectly regulates Src phosphorylation through METTL18-mediated RPL3 methylation, which influences HSP90 integrity and protein levels. The study reports that METTL18 induces actin polymerization via HSP90, leading to Src activation at key tyrosine sites.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341898,1790196718,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2024; 20(12): 4731-4749. doi: 10.7150/ijbs.96487  \nResearch Paper  \nMETTL18 functions as a Phenotypic Regulator in SrcDependent Oncogenic Responses of HER2-Negative Breast Cancer  \nHan Gyung Kim1,*, Ji Hye Kim1,*, Kyung-Hee Kim2, Byong Chul Yoo2, Sung-Ung Kang3, Young Bong Kim4, Sangmin Kim5, Hyun-June Paik6, Jeong Eon Lee7, Seok Jin Nam7, Narayanan Parameswaran8, Jeung-Whan Han9, Balachandran Manavalan1,􀀍, Jae Youl Cho1,􀀍  \n1. Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.  \n2. Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.  \n3. Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.  \n4. Department of Bio-industrial Technologies, Konkuk University, Seoul 05029, Republic of Korea.  \n5. Breast Cancer Center, Samsung Medical Center, Seoul 06351, Republic of Korea.  \n6. Department of Surgery, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.  \n7. Division of Breast, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.  \n8. Department of Physiology and Division of Pathology, Michigan State University, East Lansing, MI 48824, USA.  \n9. Research Center for Epigenome Regulation, School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.  \n* These authors contributed equally to this work.  \n􀀍 Corresponding authors: Jae Youl Cho, Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea. E-mail: [jaecho@skku.edu](jaecho@skku.edu) (J.Y.C.); Tel.: +82-31-290-7868, Balachandran Manavalan, [E-mail: bala2022@skku.edu](E-mail: bala2022@skku.edu) (B.M.); Tel.: +82-31-290-7862.  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [http://ivyspring.com/terms](http://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2024.03.21; Accepted: 2024.08.26; Published: 2024.09.03  \nAbstract  \nMethyltransferase-like (METTL)18 has histidine methyltransferase activity on the RPL3 protein and is involved in ribosome biosynthesis and translation elongations. Several studies have reported that actin polymerization serves as a Src regulator, and HSP90 is involved in forming polymerized actin bundles. To understand the role of METTL18 in breast cancer and to demonstrate the importance of METTL18 in HER-2 negative breast cancer metastasis, we used biochemical, molecular biological, and immunological approaches in vitro (breast tumor cell lines), in vivo (tumor xenograft model), and in samples of human breast tumors. A gene expression comparison of 31 METTL series genes and 22 methyltransferases in breast cancer patients revealed that METTL18 is highly amplified in human HER2-negative breast cancer. In addition, elevated levels of METTL18 expression in patients with HER2-negative breast cancer are associated with poor prognosis. Loss of METTL18 significantly reduced the metastatic responses of breast tumor cells in vitro and in vivo. Mechanistically, METTL18 indirectly regulates the phosphorylation of the proto-oncogene tyrosine-protein kinase Src and its downstream molecules in MDA-MB-231 cells via METTL18-mediated RPL3 methylation, which is also involved in determining HSP90 integrity and protein levels. In confocal microscopy and F/G-actin assays, METTL18 was found to induce actin polymerization via HSP90. Molecular events involving METTL18, RPL3, HSP90, and actin polymerization yielded Src phosphorylated at both tyrosine 419 and tyrosine 530 with kinase activity and oncogenic functions. Therefore, it is suggested that the METTL18-HSP","cbCaihOOwSaeq3zn","https://ap.wps.com/l/cbCaihOOwSaeq3zn","pdf",8909927,"English","# Abstract\n## Keywords\n# Introduction","[{\"question\":\"What is METTL18, and what biochemical activity does it have in this study?\",\"answer\":\"METTL18 is described as a histidine methyltransferase. It has histidine methyltransferase activity on the RPL3 protein, linking it to ribosome biosynthesis and translation elongation.\"},{\"question\":\"How does METTL18 relate to HER2-negative breast cancer outcomes?\",\"answer\":\"METTL18 is highly amplified and its expression is elevated in HER2-negative breast cancer patients. Higher expression is associated with poor prognosis, and METTL18 loss reduces metastatic responses in vitro and in vivo.\"},{\"question\":\"What mechanism connects METTL18 to Src and actin polymerization?\",\"answer\":\"METTL18 indirectly regulates Src phosphorylation through METTL18-mediated RPL3 methylation, which influences HSP90 integrity and protein levels. The study reports that METTL18 induces actin polymerization via HSP90, leading to Src activation at key tyrosine sites.\"}]","METTL18 functions as a Phenotypic Regulator in Src-Dependent Oncogenic Responses of HER2-Negative Breast Cancer | PDF",1790044283,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ded20fcdc38e93c09880963c61018cce.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c89abc069e415d03430de5cf28a21b4.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2df319ad6e7d6eec91560fc321d50adc.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c604c98ab04a03b6a0c6c548eeac93c0.webp",980,1268]